David R. G. Littlejohn

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Viviana Galimberti, Bernard F. Cole, Stefano Zurrida et al. · The Lancet Oncology · 2013 · 1.2K citations · Full text

Ibcsg 23–01, Surgical Pathology, Sentinel-node Micrometastases +5

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Tailored lateral sphincterotomy for anal fissure

David R. G. Littlejohn, Graham L. Newstead · Diseases of the Colon & Rectum · 1997 · 136 citations

S3-1: Update of International Breast Cancer Study Group Trial 23-01 To Compare Axillary Dissection Versus No Axillary Dissection in Patients with Clinically Node Negative Breast Cancer and Micrometastases in the Sentinel Node.

V. Galimberti, BF Cole, Stefano Zurrida et al. · Cancer Research · 2011 · 44 citations

Surgical Oncology, Breast Oncology, Breast Cancer Events +19

OPTIMAL NUMBER OF SENTINEL NODES AFTER INTRADERMAL INJECTION ISOTOPE AND BLUE DYE

Kenny S.‐S. Low, David R. G. Littlejohn · ANZ Journal of Surgery · 2006 · 21 citations